Microenvironment‐Responsive Three‐Pronged Approach Breaking Traditional Chemotherapy to Target Cancer Stem Cells for Synergistic Inoperable Large Tumor Therapy
Yan Li(Beijing Tongren Hospital), Xin Zhang(Wuhan University), Guanghui Ma(Institute of Process Engineering), Lei Chen(Zhuzhou Central Hospital), Ruilong Zhang(Ministry of Education of the People's Republic of China), Qunwei Tang(Qingdao University of Science and Technology), Zhiguo Lü(Institute of Process Engineering)
Cited by 21
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
|Journal of the American College of Cardiology|2019|494
Preparation of Hierarchical Hollow CaCO<sub>3</sub> Particles and the Application as Anticancer Drug Carrier
|Journal of the American Chemical Society|2008|453